Skip to main content
Jia Xu, MD, Pathology, Milwaukee, WI, Ascension Columbia St. Mary's Hospital Milwaukee

JiaXuMD

Pathology Milwaukee, WI

Dermatopathology, Anatomic Pathology, Clinical Pathology

Physician

Are you Dr. Xu?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 23 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Jia Xu, MD is a board certified pathologist in Milwaukee, Wisconsin. She is currently licensed to practice medicine in Wisconsin, Virginia, and District of Columbia. She is affiliated with Ascension Columbia St. Mary's Hospital Milwaukee.

Education & Training

  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Pathology-Anatomic and Clinical, 2015 - 2019
  • University of Florida College of Medicine
    University of Florida College of MedicineClass of 2014

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2022 - 2025
  • MD State Medical License
    MD State Medical License 2019 - 2023
  • VA State Medical License
    VA State Medical License 2019 - 2022
  • DC State Medical License
    DC State Medical License 2019 - 2022
  • MA State Medical License
    MA State Medical License 2014 - 2021
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Dermatopathology

Publications & Presentations

PubMed

Press Mentions

  • Transcription Factor E2F4 Is an Indicator of Poor Prognosis and Is Related to Immune Infiltration in Hepatocellular Carcinoma
    Transcription Factor E2F4 Is an Indicator of Poor Prognosis and Is Related to Immune Infiltration in Hepatocellular CarcinomaJanuary 21st, 2021
  • Transcription Factor E2F4 Is an Indicator of Poor Prognosis and Is Related to Immune Infiltration in Hepatocellular Carcinoma
    Transcription Factor E2F4 Is an Indicator of Poor Prognosis and Is Related to Immune Infiltration in Hepatocellular CarcinomaDecember 26th, 2020
  • Singtel, NUS Develop New Approach for Quantum Key Distribution
    Singtel, NUS Develop New Approach for Quantum Key DistributionApril 23rd, 2019

Hospital Affiliations